Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.

Once target nerves are identified, Autonomix uses its proprietary radio frequency ("RF") ablation technology to kill targeted nerves, enabling a precision guided sense, treat and verify approach to ...